Open AccessLocoregional therapy and systemic cetuximab to treat colorectal liver metastases
Author(s) -
Giammaria Fiorentini,
Camillo Aliberti,
Donatella Sarti,
Paolo Coschiera,
Massimo Tilli,
Luca Mulazzani,
Paolo Giordani,
Francesco Graziano,
Alfonso Marqués González,
R. García Marcos,
Fernando Gómez Mugnoz,
Maurizio Cantore,
Stefano Ricci,
Vincenzo Catalano,
Andrea Mambrini
Publication year - 2015
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v7.i6.47
Subject(s) - medicine , cetuximab , irinotecan , common terminology criteria for adverse events , colorectal cancer , adverse effect , kras , gastroenterology , response evaluation criteria in solid tumors , hazard ratio , oncology , chemotherapy , cancer , progressive disease , confidence interval
To investigate efficacy and safety of second-line treatment with irinotecan-loaded drug-eluting beads (DEBIRI) and cetuximab (DEBIRITUX) of unresectable colorectal liver metastases.